Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More.
Kostopoulos IV, Ntanasis-Stathopoulos I, Rousakis P, Eleutherakis-Papaiakovou E, Panteli C, Malandrakis P, Angelis N, Kanellias N, Orologas-Stavrou N, Papanota A, Fotiou D, Migkou M, Gavriatopoulou M, Kastritis E, Tsitsilonis O, Terpos E, Dimopoulos MA. Kostopoulos IV, et al. Among authors: malandrakis p. J Clin Oncol. 2023 Jan 20;41(3):708-710. doi: 10.1200/JCO.22.01606. Epub 2022 Sep 30. J Clin Oncol. 2023. PMID: 36179274 No abstract available.
Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma.
Gavriatopoulou M, Terpos E, Ntanasis-Stathopoulos I, Malandrakis P, Eleutherakis-Papaiakovou E, Papatheodorou A, Kanellias N, Migkou M, Fotiou D, Dialoupi I, Roussou M, Kokkali NA, Kastritis E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: malandrakis p. Blood Cancer J. 2020 Mar 2;10(3):25. doi: 10.1038/s41408-020-0297-2. Blood Cancer J. 2020. PMID: 32123158 Free PMC article. No abstract available.
Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Fotiou D, Migkou M, Eleutherakis-Papaiakovou E, Kanellias N, Roussou M, Dialoupi I, Malandrakis P, Theodorakakou F, Kastritis E, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: malandrakis p. Hemasphere. 2020 May 21;4(3):e381. doi: 10.1097/HS9.0000000000000381. eCollection 2020 Jun. Hemasphere. 2020. PMID: 32647800 Free PMC article. No abstract available.
Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause.
Kastritis E, Kanellias N, Theodorakakou F, Psimenou E, Gakiopoulou C, Marinaki S, Roussou M, Gavriatopoulou M, Migkou M, Fotiou D, Eleutherakis-Papaiakovou E, Malandrakis P, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: malandrakis p. Leuk Lymphoma. 2020 Dec;61(13):3247-3250. doi: 10.1080/10428194.2020.1797013. Epub 2020 Jul 27. Leuk Lymphoma. 2020. PMID: 32716220 No abstract available.
Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance.
Kastritis E, Theodorakakou F, Roussou M, Psimenou E, Gakiopoulou C, Marinaki S, Gatou A, Fotiou D, Migkou M, Kanellias N, Eleutherakis-Papaiakovou E, Malandrakis P, Dialoupi I, Ntanasis-Stathopoulos I, Kostopoulos IV, Terpos E, Gavriatopoulou M, Dimopoulos MA. Kastritis E, et al. Among authors: malandrakis p. Br J Haematol. 2021 Apr;193(1):113-118. doi: 10.1111/bjh.17052. Epub 2020 Aug 23. Br J Haematol. 2021. PMID: 32829529 Free article.
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma.
Gavriatopoulou M, Βoultadaki A, Koutoulidis V, Ntanasis-Stathopoulos I, Bourgioti C, Malandrakis P, Fotiou D, Migkou M, Kanellias N, Eleutherakis-Papaiakovou E, Kastritis E, Terpos E, Dimopoulos MA, Moulopoulos LA. Gavriatopoulou M, et al. Among authors: malandrakis p. Blood Cancer J. 2020 Sep 25;10(9):93. doi: 10.1038/s41408-020-00360-9. Blood Cancer J. 2020. PMID: 32978365 Free PMC article. Clinical Trial.
Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction.
Terpos E, Ntanasis-Stathopoulos I, Papassotiriou GP, Kastritis E, Margeli A, Kanellias N, Eleutherakis-Papaiakovou E, Migkou M, Fotiou D, Roussou M, Gavriatopoulou M, Malandrakis P, Psimenou E, Papassotiriou I, Dimopoulos MA. Terpos E, et al. Among authors: malandrakis p. J Clin Med. 2020 Oct 3;9(10):3201. doi: 10.3390/jcm9103201. J Clin Med. 2020. PMID: 33022958 Free PMC article.
Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma.
Papadimitriou K, Tsakirakis N, Malandrakis P, Vitsos P, Metousis A, Orologas-Stavrou N, Ntanasis-Stathopoulos I, Kanellias N, Eleutherakis-Papaiakovou E, Pothos P, Fotiou D, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Terpos E, Tsitsilonis OE, Kostopoulos IV. Papadimitriou K, et al. Among authors: malandrakis p. Cancers (Basel). 2020 Nov 4;12(11):3245. doi: 10.3390/cancers12113245. Cancers (Basel). 2020. PMID: 33158030 Free PMC article.
Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
Terpos E, Trougakos IP, Karalis V, Ntanasis-Stathopoulos I, Sklirou AD, Bagratuni T, Papanagnou ED, Patseas D, Gumeni S, Malandrakis P, Korompoki E, Dimopoulos MA. Terpos E, et al. Among authors: malandrakis p. Am J Hematol. 2021 Sep 1;96(9):E321-E324. doi: 10.1002/ajh.26248. Epub 2021 Jun 2. Am J Hematol. 2021. PMID: 34028867 Free PMC article. No abstract available.
63 results